New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System
- 31 January 2010
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 46 (2), 395-404
- https://doi.org/10.1016/j.ejca.2009.09.010
Abstract
No abstract availableFunding Information
- Netherlands Organization for Health Research and Development (ZonMw 80-82500-98-8227)
This publication has 20 references indexed in Scilit:
- Postmarketing Surveillance for Oncology DrugsClinical Journal of Oncology Nursing, 2008
- Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysisBreast Cancer Research and Treatment, 2008
- Statins, Low-Density Lipoprotein Cholesterol, and Risk of CancerJournal of the American College of Cardiology, 2008
- Prognosis for long-term survivors of cancerAnnals of Oncology, 2007
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysisAnnals of Oncology, 2006
- Rapid and Continuous Increases in Incidence Rates of Basal Cell Carcinoma in the Southeast Netherlands Since 1973Journal of Investigative Dermatology, 2004
- Dissemination of Information on Potentially Fatal Adverse Drug Reactions for Cancer Drugs From 2000 to 2002: First Results From the Research on Adverse Drug Events and Reports ProjectJournal of Clinical Oncology, 2003
- Methodology Used for “Software for Automated Linkage in Italy” (SALI)Journal of Biomedical Informatics, 2001
- Phonetic reduction of namesComputer Programs in Biomedicine, 1984